Proteolytic processing of the potyvirus polyprotein is mainly performed by the virus-encoded NIa protease, whose cleavage sites are characterized by conserved heptapeptide sequences. Partial processing at the cleavage site present between the P3 and 6K~ cistrons by the plum pox potyvirus (PPV) NIa protease has been previously shown to occur in vitro. We have now studied the role ofpolyprotein processing at the P3-6K1 junction in vivo, using a full-length PPV eDNA clone. PPV mutant transcripts containing a histidine for glutamine substitution in the cleavage site sequence (a change that abolishes in vitro processability) are able to infect Nieotiana clevelandii plants, indicating that normal processing at the P3-6K 1 junction is not required for virus viability. However, disease symptoms were not detected and virus accumulation occurred after a second site mutation was introduced into the 6K 1 cistron during replication. This additional change did not restore the in vitro processability of the mutant heptapeptide. Changes at other positions in the heptapeptide (that only slightly altered the in vitro processability of this NIa site) were also engineered and it was found that these mutations affected the time course and severity of the symptom induction process. A possible regulatory effect on the function of the potyvirus P3 + 6K 1 protein by processing at the P3-6Kt junction is discussed in light of our present results with PPV.
Proteolytic processing of the potyvirus polyprotein is mainly performed by the virus-encoded NIa protease, whose cleavage sites are characterized by conserved heptapeptide sequences. Partial processing at the cleavage site present between the P3 and 6K~ cistrons by the plum pox potyvirus (PPV) NIa protease has been previously shown to occur in vitro. We have now studied the role ofpolyprotein processing at the P3-6K1 junction in vivo, using a full-length PPV eDNA clone. PPV mutant transcripts containing a histidine for glutamine substitution in the cleavage site sequence (a change that abolishes in vitro processability) are able to infect Nieotiana clevelandii plants, indicating that normal processing at the P3-6K 1 junction is not required for virus viability. However, disease symptoms were not detected and virus accumulation occurred after a second site mutation was introduced into the 6K 1 cistron during replication. This additional change did not restore the in vitro processability of the mutant heptapeptide. Changes at other positions in the heptapeptide (that only slightly altered the in vitro processability of this NIa site) were also engineered and it was found that these mutations affected the time course and severity of the symptom induction process. A possible regulatory effect on the function of the potyvirus P3 + 6K 1 protein by processing at the P3-6Kt junction is discussed in light of our present results with PPV.
The potyvirus genome, a 10 kb RNA molecule, is expressed through its translation into a unique polyprotein that undergoes extensive proteolytic processing . The virus-encoded NIa protease catalyses most of the proteolytic events, processing the central and C-terminal regions of the polyprotein (Fig. 1) . NIa cleavage sites are defined by conserved heptapeptides (amino acids -6 to + 1, the scissile bond located between -1 and + 1 ; Dougherty et al., , 1989 Garcia et al., 1989b) and seven of these sequences (named A to F and v; Fig. 1 profiles; for review see Riechmann et al., 1992; Dougherty et al., 1990) . Nevertheless, there is still controversy over whether the A site is actually used in vivo and, in fact, the nature of the A heptapeptide as an NIa cleavage site has often been overlooked. This heptapeptide is present at similar positions in the polyproteins of all 12 potyviruses sequenced to date see below) and it has been shown in cell-free proteolytic processing experiments that the plum pox virus (PPV) site A is partially cleaved in vitro (Garcfa et al., 1992) . In addition, the presence in plants infected by tobacco vein mottling virus of two proteins of 42 and 37 kDa that immunoreact with antibodies raised against a bacterially expressed 42 kDa protein corresponding to the P3+6K 1 cistron (Fig. 1 ) supports the existence of cleavage site A and suggests that, in vivo, it might also be only partially processed (Rodriguez-Cerezo & Shaw, 1991) . Therefore, three different gene products would originate from this region of the potyvirus polyprotein: P3, 6K1 and P3 +6K a. However, in vitro processing at tobacco etch virus (TEV) site A has also been assayed and, in this case, no cleavage was observed (Parks et al., 1992) . The presence of the presumed 6K t peptide in infected plants has not yet been observed for any potyvirus.
To gain insight into the nature of the A heptapeptide 0001-2832 © 1995 SGM as an in vivo NIa cleavage site and to determine whether or not its processing is an essential step in the virus lifecycle, we have introduced several mutations into a fulllength PPV cDNA clone (from which infectious transcripts can be synthesized; Riechmann et al., 1990 ) that alter the PPV A heptapeptide. These mutations had been previously used to determine the partial processing in vitro of PPV site A (Garc/a et al., 1992) . The Q1116H mutation changes the highly conserved glutamine residue at position -1 (see Fig. 1) ; it was subsequently shown that this change resulted in a heptapeptide that was unable to be processed in vitro. The Q1111N and S1117A exchanges transform, when introduced together (QllllN,Slll7A mutant), the sequence of the A heptapeptide into that of the F heptapeptide ( Fig. 1) . The natural NIa cleavage site F (NIb-CP junction) is very efficiently cleaved, both in vitro and in vivo. However, these changes only slightly affected cleavage at the NIa site A. These mutations (for details of the construction procedure, see Garc/a et al., 1992) were introduced into the full-length PPV clone pGPPV (Riechmann et al., 1990) by fragment replacement, creating plasmids pGPPV Qlll6H, pGPPV qnn~'sllx7A, pGPPV Q1111z~ and pGPPV smTA (Fig. 1) . RNA synthesis from linearized plasmid templates and inoculation of young Nicotiana clevelandii plants with the resulting capped transcripts were performed as previously described (Riechmann et al., 1990 (Riechmann et al., , 1991 ; the transcripts produced in vitro from pGPPV and other cDNA clones were given the prefix 't' (i.e. tPPV). N. clevelandii plants inoculated with tPPV (wild-type) transcripts began to develop typical systemic symptoms in the uninoculated upper leaves 7-10 days after inoculation (Riechmann et at., 1990) . All of the 10 plants inoculated with PPV Ql116n mutant transcripts remained asymptomatic during a period of 31 days postinoculation (d.p.i.). To test whether the Qlll6H exchange was a lethal mutation that made tPPV Q111~H unable to replicate (and therefore unable to establish an infection), or was not lethal but hampered in some way the normal virus life-cycle (since no symptoms were detected), crude RNA samples from upper leaves of plants inoculated with tPPV Qm6H were prepared and subjected to RT-PCR as described previously (Riechmann et at., 1991) . The oligodeoxynucleotides used as primers for the detection of viral RNA sequences were: primer a, 5' AACAGCCTGGTCGAC 3' (complementary to positions 3627 to 3641 of PPV RNA; However, viral sequences were amplified from two extracts of leaves harvested at 31 d.p.i. (Fig. 2a, lane 5) indicating that in these tPPVqll16H-inoculated plants the virus RNA had systemically propagated. In accordance with this result, PPV capsid protein (CP) could not be detected in Western blots at 15 d.p.i. (Fig. 2b, lane 3) , but high levels of CP were present in these asymptomatic plants 31 d.p.i. (Fig. 2 b, lane 4 ; immunological detection of PPV CP was performed as previously described; Riechmann et al., 1990) . The RT-PCR products (that correspond to the whole 6K1 peptide and the C terminus of P3 protein; see Fig. 2a ) derived from systemically infected leaves, as well as a product obtained from the inoculated leaves of one of these plants (also harvested at 31 d.p.i.), were sequenced using the primers that were employed for their synthesis and the fmol DNA Sequencing System (Promega), essentially according to the supplier's instructions. The Q l l l 6 H mutation was present in the RNA sequence amplified from inoculated leaves, as well as in those obtained from systemic leaves. Surprisingly, an additional mutation that must have been introduced in vivo during virus replication was detected ( Fig. 3a and data not shown). This second mutation, a G to A exchange at nucleotide position 3513, was detected in the inoculated leaf, although the wildtype G residue was predominant in the population of PPV genomes, as inferred from the intensity of the respective bands in the autoradiogram (Fig. 3 a) . However, in the samples from systemically infected leaves, the second-site mutation (A residue) was highly predominant over the wild-type nucleotide, indicating that most of the RNA molecules that were present in these leaves carried this additional mutation (Fig. 3 a and data not shown)• This nucleotide change at position 3513 results in the substitution of a threonine for an alanine residue, seven amino acids downstream from the scissile bond of the NIa A site (Fig. 3 a) . No other exchanges were detected in the sequenced region. N. clevelandii plants were inoculated with a crude extract prepared from systemic leaves of two plants in which the Q1116H,A1123T second mutant was detected. Symptoms identical to those induced by wild-type PPV developed in these plants (data not shown), suggesting that the pathogenicity of the virus, which had been greatly diminished by the Q l l l 6 H exchange, was restored during its replication in vivo. The progeny virus present in these plants, and those derived from one more round of infection/replication, were analysed as above. In most cases, both Q1116H and A1123T changes were detected together in the same sample. None of the single 
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m u t a n t by selection pressure favourable to wild-type R N A . To test if the A1123T second-site m u t a t i o n p r o d u c e d a recovery of the in vitro processability o f the Q l l l 6 H m u t a n t site A, b o t h changes were introduced together in plasmid p G G P 3 A V wt (Garcia et al., 1992) , creating plasmid p G G P 3 A V QIxl~r~,Allz3T (Fig. 3b) . T r a n s l a t i o n in a rabbit reticulocyte lysate o f transcripts synthesized from these plasmids resulted in a polypeptide with electrophoretic mobility c o r r e s p o n d i n g to its expected size (54"5 k D a ; Fig. 3b, lanes 1, 3 and 5) . Processing at sites A or B would give rise to N -t e r m i n a l fragments o f 39-4 and 45"2 kDa, respectively, and polypeptides with these electrophoretic mobilities were readily detected when the translation products derived from tGGP3AV wt were incubated with an extract of E. coli cells that express the NIa protease (Fig. 3b, lane 2; proteolytic processing assays were performed as previously described; Garcia et al., 1992) . The histidine for glutamine substitution at position -1 of the A heptapeptide present in products derived from tGGP3AV qm~rI precluded the generation of the 39.4 kDa band after the proteolytic incubations (Fig. 3b, lane 4 ; Garcia et al., 1992) . The processability of this mutant heptapeptide was not rescued by the second mutation Al123T, since the 39.4 kDa band was not generated from products of tGGP3AV Q1116n' Al123T either (Fig. 3 b, lane 6) .
N. clevelandii plants were also inoculated with tPPV Q1111•'s1117A, tPPV Q1111z~ and tPPV sll17A. While tPPVQllllN'S1117Aand tPPV Q1111z~ had a reduced pathogenicity in view of the extremely mild symptoms that they induced, tPPV s1117A mutant was more virulent than tPPV wt (data not shown). The time course of symptom development was also altered by this mutation; tPpVSmTA-inoculated plants developed symptoms 5-7 d.p.i. (i.e., earlier than plants inoculated with wild-type transcripts). Viral RNA was readily detected by RT-PCR at 15 d.p.i, in systemic leaves from plants inoculated with these mutants (Fig. 2a, lanes 6, 7 and 8 ). Similar high levels of CP were detected in plants inoculated with each of these three mutants and with tPPV wt, indicating that the differences in the severity of the induced symptoms apparently did not correlate with differences in virus accumulation (Fig. 2b , compare lanes 2, 5, 6 and 7).
As above, viral RNA sequences were amplified from systemic leaves and the PCR products were sequenced. The presence of QllllN,Slll7A, QllllN and Slll7A mutations in the corresponding viral progeny was confirmed. No in vivo-introduced mutations were detected in the sequenced region. Progeny virus of these three mutants maintained the corresponding parental phenotype with regard to the symptom induction process.
All these data indicated that the QllllN,Slll7A, QllllN and SII17A mutations were stable when in the PPV genome.
As described above, the development of a normal PPV life-cycle was hampered by the Qlll6H mutation, yet PPV Ql116H mutant was able to establish an infection in N. clevelandii plants, indicating that a cleavable NIa site A is not an essential requirement for virus viability. This conclusion relies on the assumption that the Qlll6H mutation abolishes in vivo processing of the PPV site A in a similar way as it does in vitro (Garcia et al., 1992) , but such assumption is warranted by the current abundance of data on potyvirus proteolytic processing.
Changes at the highly conserved -1 position have been engineered in several cleavage sites of different potyviruses and their effects assayed in various systems. They have always been found to abolish the cleavability of the resulting mutant sites (Dougherty et al., , 1989 Garcia et al., 1989a) . In addition, a replacement of the glutamine residue present at the -1 position of the NIa site E (NIa-NIb junction) (a change similar to Q1116H that also abolishes in vitro cleavability; Garcia et al., 1989a) was introduced into the PPV genome and the resulting mutant transcripts were unable to establish an infection in N. clevelandii plants (data not shown). Mutation of the -1 glutamine residue of the TEV NIa site D (6K~-NIa junction) also eliminates virus viability (Restrepo-Hartwig & Carrington, 1994) . These results indicate the capability of -1 glutamine mutations to render viral genomes non-viable when introduced into in vivo-functional NIa sites, and therefore reinforces the interpretation of the processing at NIa site A as somehow dispensable. This dispensability would imply that the full-length product (i.e. P3+6KI) is the functional protein. On the other hand, the fact that the Qll 11N,S1117A, QllllN and Slll7A (as well as other mutations not described in this article; J. L. Riechmann & J.A. Garcia, unpublished results) were viable and stable suggests that a certain degree of tolerance towards amino acid exchanges exists in the heptapeptide and surrounding sequence when a cleavable site is conserved.
In vivo processing of the A site in the normal life-cycle of PPV could be a way to regulate the activity (currently unknown) of the P3 + 6K1 protein. Such a regulatory role for NIa site A processing seems to be appropriate if the characteristics of this part of the polyprotein are considered, since this site precisely defines the boundary between a region (P3) with a very low level of sequence similarity among different potyviruses and another one (6K~) that is much more conserved ; for additional potyvirus genomic sequences see Johansen et al., 1991; Bowman Vance et al., 1992; Jayaram et al., 1992; Nicolas & Lalibert6, 1992; Yeh et al., 1992; Gough & Shukla, 1993; Puurand et al., 1994; Gunasinghe et al., 1994) . Being the function of the NIa site A to provide a regulatory step, it is understandable that this site be present in all the potyviruses sequenced to date. The fact that cleavage at the TEV site A was not detected in vitro (Parks et al., 1992) could also fit into this model, since TEV may have evolved to make this level of control dispensable. Interestingly, the TEV NIa site A is less well conserved (when compared to the rest of TEV NIa cleavage sites) than those A sites of the rest of potyviruses for which data are available Garcia et al., 1992) .
In summary, the fact that tPPV °l~a6n was able to initiate an infection indicates that a cleavable NIa site A is not an essential requirement for such a process. However, the drastic effects that mutations at this cleavage site have on the course of virus infection, as well as the appearance of a second mutation and the reversion to the wild-type sequence, suggest that processing at the P3-6K 1 junction plays a relevant role in the life-cycle of PPV and that proper cleavage contributes to the timecourse of symptom development and severity.
